Not using X anymore, after so many years. it’s no longer compatible with my values

Discuss testis-sparing surgery with frozen section examination in patients with a high likelihood of having a benign testicular tumour which are suitable for enucleation. #EAUguidelines #TesticularCancer https://t.co/AD4UHug8Gl

🆕 At the start of ADT offer luteinising hormone-releasing hormone antagonists or orchiectomy to patients with impending clinical complications, like spinal cord compression or bladder outlet obstruction. #ProstateCancer #EAUguidelines https://t.co/0ax5QuNs6e

This study was led by two top Dutch trainees: Drs. Sofie Tolmeijer & Emmy Boerrigter, as part of a long-standing collaboration with Profs Niven Mehra and Nielka van Erp (RadboudUMC) and ably supported by several members of my lab @VanProstateCtr 👏

In our new paper in @CCR_AACR: plasma ctDNA% in pts with mCRPC after 4 wks of abi/enza tx inform on subsequent duration of response (outperforming clinical variables). Can on-treatment ctDNA changes guide an early treatment switch or intensification? https://t.co/IqAdiNwBNN

In pN0 patients with ISUP grade group 4–5 and pT3 ± positive margins, offer adjuvant intensity-modulated radiation therapy/volumetric modulated arc therapy plus image-guided radiation therapy. #EAUguidelines #ProstateCancer https://t.co/0ax5QuNs6e

Meet the Editorial Board: Luca Cindolo expert in BPH/LUTS and minimally invasive surgery. Thanks for the great support to the journal! @lucacindolo #editorial #pcsm #team #urosome

🆕 During active surveillance, perform MRI and repeat biopsy if PSA is rising (PSA-doubling time < 3 years). #EAUGuidelines #ProstateCancer https://t.co/0ax5QuNs6e

Patients with HR localized disease, M0 on conventional imaging but one bone lesion on PSMA PET/CT: arguments for a surgical approach +/- radiotherapy +/- systemic treatment. Presented by @BertrandTOMBAL @UCLouvain_be. #EAU23 @zklaassen_md > https://t.co/reXULVI3iI @onco_uroloog

@JonathanSOBrien & @declangmurphy deliver one of highest quality videos of #EAU23 with slick, professional production values. This is how all videos should be put together! If only rest of our community had skills of this group. Key message: RP is safe/feasible after #Lutectomy

Now On:Ig!! Follow us for esclusive content! https://t.co/5QKqVdGieS. #UroSoMe #pcsm #instagood #social

Find out more on the Schelin Catheter for analgesia during Rezum: https://t.co/yx8oOfi5mK @lucacindolo @bsc_urology @BSCEMEA_UroPH #anagesia #Practice

Our UCSF prostate cancer cohort shows that men who develop a detectable serum PSA >6 months after surgery may still have excellent long-term outcomes: https://t.co/Xu6nxH625T @JSzymaniakMD @cosimodenunzio

Podcasts are a useful way to provide public education about #prostatecancer genetics: https://t.co/kdqljtXJ9U #podcast #pcsm @LoebStacy

Glad to see that our modest single arm phase 2 NEAR trial of neoadjuvant APA was cited as the top stories published in @pcan_journal in 2022! Kudos to the team for pushing this through 💪🏻 @JanssenUS @MundleSuneel @KaeJackTay @ravikanesvaran @JoeYeong https://t.co/KLKr6D6arU

Metastatic prostate cancer patients benefit from patient involvement in decisions: https://t.co/5mxiuGO1OV @Frank_Shoes @CaPsurvivorship @TDorffOnc @cosimodenunzio @onco_uroloog @AarmstrongDuke

How do we actually communicate risks of cancer and other cause death in prostate cancer consults? Turns out we fail to quantify cancer mortality, life expectancy, and survival benefit with treatment in 34% , 31%, and 71% of consults! https://t.co/xjgQmSMMyg

@pcan_journal selected the most significant research papers on #ProstateCancer 👉 https://t.co/BCQlWpKOsc 🎉 Proud of our team @PeltierAlexand8 @ThRoumeguere @yassir_belahsen 👉

Sub-stratification of current NCCN high-risk prostate cancer may lead to better patient prognostication and counseling: https://t.co/iMo3LVjkg2 @ahmedmansour1st, @Garg_H, @drfurkandursun, @lissmike,@DharamKaushik5,@SvatekRob @lucacindolo

Excited this paper is out shedding light on sleep disturbances in #prostatecancer survivors. Great work leading @FredGong_ 👏🏻💤